Skip to content
The Policy VaultThe Policy Vault

Scemblix (asciminib tablets) — Cigna

Myeloid/lymphoid neoplasms with eosinophilia

Initial criteria

  • Patient age ≥ 18 years
  • The tumor has an ABL1 rearrangement

Approval duration

1 year